Author:
Barreiro Karina,Holthofer Harry
Funder
FRIAS program of the Albert-Ludwigs University, Freiburg.
EU-Innovative Medicines Initiative (IMI) Program “Biomarker Enterprise to Attack Diabetic Kidney Disease” (BEAt-DKD)
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Histology,Pathology and Forensic Medicine
Reference99 articles.
1. Akers JC, Gonda D, Kim R, Carter BS, Chen CC (2013) Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neuro-Oncol 113:1–11
2. Alter ML, Kretschmer A, Von Websky K, Tsuprykov O, Reichetzeder C, Simon A, Stasch JP, Hocher B (2012) Early urinary and plasma biomarkers for experimental diabetic nephropathy. Clin Lab 58:659–671
3. Alvarez ML, Distefano JK (2013) The role of non-coding RNAs in diabetic nephropathy: potential applications as biomarkers for disease development and progression. Diabetes Res Clin Pract 99:1–11
4. Alvarez ML, Khosroheidari M, Kanchi Ravi R, DiStefano JK (2012) Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. Kidney Int 82:1024–1032
5. Alvarez S, Suazo C, Boltansky A, Ursu M, Carvajal D, Innocenti G, Vukusich A, Hurtado M, Villanueva S, Carreno JE, Rogelio A, Irarrazabal CE (2013) Urinary exosomes as a source of kidney dysfunction biomarker in renal transplantation. Transplant Proc 45:3719–3723
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献